がん診断のためのナノセンサー特性評価とCRISPR-Cas媒介尿バイオマーカー検査
48 Views
•
03:23 min
•
December 8th, 2023
DOI :
December 8th, 2023
•
48 Views
Audrey E. Van Heest1, Feiyang Deng1, Renee T. Zhao2, Nour Saida Harzallah2,3, Heather E. Fleming3,4, Sangeeta N. Bhatia2,3,4,5,6,7,8, Liangliang Hao1,2,3
1Department of Biomedical Engineering, Boston University, 2Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 3Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 4Howard Hughes Medical Institute, 5Broad Institute of Massachusetts Institute of Technology and Harvard, 6Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 7Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 8Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
Transcript
From the series
がん診断のためのCRISPR-Cas合成尿バイオマーカー検査
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved